Press "Enter" to skip to content

Pharma Reviews

Drug developer Tesaro explores sale

The company, which has a market capitalization of $1.92 billion, said it does not comment on rumor or speculation. Original source: https://health.economictimes.indiatimes.com/news/pharma/drug-developer-tesaro-explores-sale/66662895?utm_source=RSS&utm_medium=ETRSS

FDA declines to approve Aquestive’s Viagra rival

Aquestive Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its erectile dysfunction treatment and sought additional data. Original source:…

FDA approves new drug to treat travelers’ diarrhea

FDA approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E.…